Mp84-20 Bioinformatic Analysis Utilizing the Androgenic Suppressive Effect Identified Promising Candidate Drugs for Reprogramming Docetaxel-Resistant Castration-Resistant Prostate Cancer

Journal of Urology - Netherlands
doi 10.1016/j.juro.2016.02.2244
Full Text
Abstract

Available in full text

Categories
Urology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel

Japanese Journal of Urology
Urology
2013English

Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review

European Oncology and Haematology
OncologyHematology
2012English

Effect of Dutasteride on Castration‑resistant Prostate Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2017English

Pcn346 - Disease Specific Cost Analysis of the Nonmetastatic Castration-Resistant Prostate Cancer and Metastatic Castration-Resistant Prostate Cancer Health States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Guideline Adherence in Docetaxel Treatment of Castration Resistant Prostate Cancer (CRPC) Patients in a Real-World Population: The Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

The Effects of Matrine in Combination With Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer

Cancer Management and Research
Oncology
2019English

Aggressive Variants of Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Visceral Disease in Castration-Resistant Prostate Cancer

European Urology
Urology
2014English

Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy